LPL and hyperlipidemia: Pro-inflammatory cytokines such as IL-1β, TNF-α, and IL-17 disrupt systemic lipid homeostasis by suppressing lipoprotein lipase and promoting hepatic lipogenesis, leading to hyperlipidemia [21, 22].